title: Lower levels of TSH are associated with a lower risk of papillary thyroid cancer in patients with thyroid nodular disease: thyroid autonomy may play a protective role.
abstract: Higher TSH values, even within normal ranges, have been associated with a greater risk of thyroid malignancy. The relationship between TSH and papillary thyroid cancer (PTC) has been analyzed in 10 178 patients submitted to fine needle aspiration of thyroid nodules with a cytology of PTC (n=497) or benign thyroid nodular disease (BTND, n=9681). In 942 patients, submitted to surgery (521 from BTND and 421 from PTC), the histological diagnosis confirmed an elevated specificity (99.6%) and sensitivity (98.1%) of cytology. TSH levels were significantly higher in PTC than in BTND both in the cytological and histological series and also in patients with a clinical diagnosis of multinodular goiter (MNG) and single/isolate nodule (S/I). A significant age-dependent development of thyroid autonomy (TSH <0.4 microU/ml) was observed in patients with benign thyroid disease, but not in those with PTC, diagnosed both on cytology and histology. In patients with MNG, the frequency of thyroid autonomy was higher and the risk of PTC was lower compared to those with S/I. In all patients, the presence of thyroid auto-antibodies (TAb) was associated with a significant increase of TSH. However, both in TAb positive and TAb negative patients TSH levels were significantly higher in PTC than in BTND. Our data confirm a direct relationship between TSH levels and risk of PTC in patients with nodular thyroid diseases. Thyroid autonomy conceivably protects against the risk of PTC, while thyroid autoimmunity does not play a significant role.
authors.affiliation: Department of Endocrinology, University of Pisa, Pisa, Italy. e.fiore@ao-pisa.toscana.it
authors.forename: E
authors.initials: E
authors.lastname: Fiore
authors.forename: T
authors.initials: T
authors.lastname: Rago
authors.forename: M A
authors.initials: MA
authors.lastname: Provenzale
authors.forename: M
authors.initials: M
authors.lastname: Scutari
authors.forename: C
authors.initials: C
authors.lastname: Ugolini
authors.forename: F
authors.initials: F
authors.lastname: Basolo
authors.forename: G
authors.initials: G
authors.lastname: Di Coscio
authors.forename: P
authors.initials: P
authors.lastname: Berti
authors.forename: L
authors.initials: L
authors.lastname: Grasso
authors.forename: R
authors.initials: R
authors.lastname: Elisei
authors.forename: A
authors.initials: A
authors.lastname: Pinchera
authors.forename: P
authors.initials: P
authors.lastname: Vitti
mesh_terms: D001323:Autoantibodies / Q000097:blood; D044963:Biopsy, Fine-Needle; D002291:Carcinoma, Papillary / Q000097:blood* / Q000473:pathology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D011379:Prognosis; D012307:Risk Factors; D013960:Thyroid Function Tests; D013964:Thyroid Neoplasms / Q000097:blood* / Q000473:pathology; D016606:Thyroid Nodule / Q000097:blood* / Q000473:pathology; D013972:Thyrotropin / Q000097:blood*
chemical_list: D001323:Autoantibodies; D013972:Thyrotropin